Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, today announced that it is scheduled to present at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Thursday, January 15, 2015 at 12:00 p.m. PST. Chris Garabedian, Sarepta’s president and chief executive officer, will be the presenter.
Help employers find you! Check out all the jobs and post your resume.
